Singapore Scientists Integrate AI Tools To Improve Diagnosis of Heart Disease
Margaretta Colangelo
Top Thought Leadership Voice | Leading AI Analyst and Writer | AI Newsletter with 56,500+ subscribers
Singapore is a hotbed of AI innovation. 80 of the world’s top 100 technology companies have a strong presence in Singapore enabling innovation and accelerating adoption of AI. This month, a team of leading physicians, AI scientists, and tech experts at the Agency for Science, Technology and Research (A*STAR), National Heart Centre Singapore (NHCS), National University Health System (NUHS) and Tan Tock Seng Hospital (TTSH) announced the development of a new AI platform called APOLLO (AI-driven national Platform for CT cOronary angiography for clinicaL and industriaL applicatiOns) to help doctors improve diagnosis and treatment of cardiovascular disease.
The APOLLO platform integrates several AI toolkits that analyze Computed Tomography Coronary Angiography (CTCA) scans into clinical workflow. By integrating AI toolkits with diagnostic and prognostic capabilities, the platform enables them to work functionally together to provide automated anonymization, reporting, calcium scoring, epicardial fat, coronary stenosis and plaque quantification. This is a really practical step forward because the AI tools are integrated into one platform so it's much more efficient for doctors.
The AI tools that are integrated on the APOLLO platform were developed by A*STAR scientists at?Bioinformatics Institute (BII), Institute for Infocomm Research (I2R), and the Institute of High Performance Computing (IHPC) in Singapore.
APOLLO Team
Collaborations
The APOLLO team is interested in expanding industry collaborations. If you are interested in collaborating on the APOLLO project please contact the team at?[email protected]
Coronary Artery Disease
Coronary artery disease (CVD) is the world’s number one killer. Over 18 million people die every year from CVD. It affects 20% of people over 65 years of age and causes 33% of deaths globally. The number of coronary artery disease cases is growing due to population aging and increasing prevalence of diabetes.
Computed tomography (CT) is the first line of investigation for coronary artery disease. This is?an imaging test that helps determine if plaque buildup has narrowed the coronary arteries that supply blood to the heart. Plaque (composed of fat, cholesterol, and calcium) builds up over time on the inner lining of the arteries.?This can reduce, and in some cases, completely block blood flow to the heart.
The Traditional Method
New AI-Based Approach
The new APOLLO platform allows accurate assessment of plaque burden in coronary artery disease and shortens the processing time for image analysis and diagnosis. The scientists are building a large sharable, de-identified, PDPA compliant curated digital warehouse of CT real-world data from 3 hospitals in Singapore. The integrated APOLLO AI platform will be used for anonymization and reporting of coronary calcium, epicardial fat, stenosis and plaque quantification in large scale clinical trials.
The APOLLO team will assess usability and workflow integration and the ability to provide a rapid assessment of patients’ conditions using AI solutions. The team plans to test the AI toolkits in several different hospitals and in clinical trials.?The platform can provide objective and consistent clinical trial end-point measurements at a cheaper cost. In return, this will increase the probability of success and reduce timelines in drug discovery and development.
Benefits of Using AI
领英推荐
4 AI modules
The APOLLO platform consists of four AI modules each of which performs a different AI analyses of CT images to detect high-risk plaque and risk-stratify patients.?
Alleviating Burden to the Healthcare System
This AI-enabled coronary CT angiography can significantly alleviate the burden to the healthcare system.?
Current Industry Partners
Collaborations
The APOLLO team is interested in expanding industry collaborations. If you are interested in collaborating on the APOLLO project please contact the team at?[email protected]
Subscribe, Comment, Join Group
I'm interested in your feedback - please leave your comments.
To subscribe to the AI in Healthcare Milestones newsletter please click here.
To join the AI in Healthcare Milestones Group please click here.
Copyright ? 2022 Margaretta Colangelo. All Rights Reserved.
This article was written by Margaretta Colangelo. Margaretta is a leading AI analyst who tracks significant milestones in AI in healthcare. She consults with AI healthcare companies and writes about some of the companies she consults with. Margaretta serves on the advisory board of the AI Precision Health Institute at the University of Hawai?i?Cancer Center @realmargaretta
Integrated Healthcare ~ Forbes Expert Panel ~ Behavioral Health Strategist ~ Keynote Speaker ~ Mental Health Advisor ~ Digital Health ~ Regulatory Affairs ~ Healthcare Innovation
8 个月Absolutely fascinating to see how AI is revolutionizing healthcare in Singapore, especially with the potential to enhance cardiac care. This collaboration is a significant step for medical tech!
--
2 年Thank you Margaretta for another insightful and inspiring look into the deeper side of science.
| Especialista Consultor en Psiquiatría y Psicología Médica- Neurociencias.
2 年Margarita te felicito tu publicación es revolucionaria.-
?? AI Expert & Ethicist | Generative AI & RAG Designer | OpenAI and Google AI expert| Author & Speaker| Business Visionary
2 年Margaretta Colangelo Another meaningful masterpiece by Margaretta!!!
I owe Zuck $29.8 for lunch. Please buy a subscription to Engage Ai
2 年Colin Priest